Title | MYB expression: Potential role in separating adenoid cystic carcinoma (ACC) from pleomorphic adenoma (PA). |
Publication Type | Journal Article |
Year of Publication | 2016 |
Authors | Moon A, Cohen C, Siddiqui MT |
Journal | Diagn Cytopathol |
Volume | 44 |
Issue | 10 |
Pagination | 799-804 |
Date Published | 2016 Oct |
ISSN | 1097-0339 |
Keywords | Adenoma, Pleomorphic, Biomarkers, Tumor, Biopsy, Fine-Needle, Carcinoma, Adenoid Cystic, Diagnosis, Differential, Humans, Oncogene Proteins v-myb, Sensitivity and Specificity |
Abstract | BACKGROUND: Basaloid tumors of the salivary gland both benign and malignant comprise ACC, cellular PA, basal cell adenoma (BCA), and basal cell adenocarcinoma. Rendering a diagnosis given a limited biopsy or fine needle aspiration (FNA) sample proves challenging. Activation of MYB by gene fusion has been found in salivary gland ACCs; therefore we investigated the utility of MYB immunohistochemistry (IHC) as a tool for distinguishing ACCs from other basaloid neoplasms. METHODS: We selected 48 cases of ACC (11 FNA blocks [CB]), 37 histologic resections [HR]), 74 PA (36 CB, 38 HR), and 18 BCA (7 CB, 11 HR). FNA CB showed 82% of ACCs (N = 9 of 11) as positive for MYB nuclear staining whereas 68% of ACCs (N = 25 of 37) were positive in HR. RESULTS: All PA were negative for MYB nuclear staining in both CB (N = 0 of 36) and HR (N = 0 of 38). CB showed 29% of BCA (N = 2 of 7) as positive for MYB nuclear staining and 55% (N = 6 of 11) positive in HR. Both ACC and BCA showed significantly higher mean staining intensity than PA in both CB and HR (P < 0.0001). When comparing ACC and BCA, significantly higher mean staining intensity was observed in CB (P = 0.02382) but not in HR (P = 0.42952). CONCLUSION: MYB nuclear staining may prove useful in separating ACC from PA and BCA, especially in limited cellular samples. Diagn. Cytopathol. 2016;44:799-804. © 2016 Wiley Periodicals, Inc. |
DOI | 10.1002/dc.23551 |
Alternate Journal | Diagn Cytopathol |
PubMed ID | 27491495 |
Related Faculty:
Momin Siddiqui, M.D.